BWS Dialogues

Pharmaceutical sponsors and their contract organizations, such as contract development and manufacturing organizations (CDMOs), need to share a lot of information. But typical data sharing processes are highly manual, during both extraction and ingestion, and thus inefficient and error-prone. So how can partner organizations begin to integrate their digital systems, to create more efficiency? Davi...

Your audience is asking questions on the internet. Are you answering them? Search engine optimization (SEO) is one of the best ways to show up for your audience where they are in their buyer journey. In the AI-era of “Is SEO Dead?” and “What’s the future of search?”, we sat down with Mike MacMillan to get his insights on what SEO best practices look like today. With over 20 years of digital market...

Video is a powerful marketing tool. Yet B2B marketers often struggle to develop a clear strategy for using video. The tactics can feel daunting too. What types of videos should we make? What types of topics best lend themselves to video? What if our staff is nervous about being in front of the camera? How do we get the best ROI? To address these questions, we sat down with Robert Weiss, the execut...

Pharmaceutical manufacturing, quality, and supply chain management can all benefit from the wise application of artificial intelligence (AI). But what approach should pharma manufacturers take to harnessing AI in these areas? And what are the risks? To explore these questions, we sat down with Pat Day, a principal consultant at Lachman Consultants. Following more than 25 years working inside the p...

B2B science marketing is changing, and yet certain fundamentals remain the same. How should life sciences companies plan and execute their marketing campaigns today? To explore that question, we sat down with Debra Harrsch, CEO of Brandwidth Solutions, and Peter Harrsch, PhD, Brandwidth’s chief science officer. Reflecting on what they have seen and learned since the agency’s founding 20 years ago,...

For B2B companies serving customers in the life sciences — in areas such as bio/pharmaceutical CDMO services, diagnostics, life sciences instrumentation, and laboratory software — creating and maintaining an engaging website is a challenging undertaking. Potential customers are smart and highly educated, and need a sufficient level of detail to inform their buyer’s journey. But they are also busy,...

The U.S. administration is pushing for the onshoring of pharmaceutical production. But is there a sufficient supply of qualified people to staff expanded bioprocessing operations? To explore that question, we sit down with Eric Langer, the president and managing partner of BioPlan Associates. For more than 20 years, his firm has been publishing the Annual Report of Biopharmaceutical Manufacturing...

On August 16, the administration issued an executive order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The plan begins by stockpiling a six-month supply of 26 critical drugs, with the goal of expanding to a list of 86 essential medicines. What does this mean for pharmaceutical manufacturing, contract development and manufacturing organizations (CDMOs), and the broader...